Sinopharm Zhijun (Shenzhen) Pingshan Pharmaceutical Co., Ltd.

Sinopharm Zhijun (Shenzhen) Pingshan Pharmaceutical Co., Ltd. was established in July 1990 and is affiliated with the Pharmaceutical Business Division of China National Pharmaceutical Group, Sinopharm Group Co., Ltd., and Sinopharm Yizhi Pharmaceutical Co., Ltd. It is also a core industrial enterprise under Sinopharm Yizhi Pharmaceutical Co., Ltd. In 2003, Sinopharm Zhijun (Shenzhen) Pingshan Pharmaceutical Co., Ltd. was rated as a Food and Drug Safety Engineering Production Base by the Guangdong Pharmaceutical Industry Association, and in 2010 it was honored with titles such as Vanguard of Guangdong Province's Traditional Chinese Medicine Industry. The company regards product quality as its lifeblood and has established a relatively complete quality control and quality assurance system. The company currently has two production bases. The Baguiling plant area has production lines for traditional Chinese medicine products in dosage forms such as oral liquids, mixtures, oral solutions, lotions, hard capsules, tablets, and granules, and has fully passed the new version of GMP certification. The Pingshan base is mainly positioned as a production base for non-penicillin and non-cephalosporin oral solid preparations, Western medicine oral liquids, Chinese patent medicines, health products, and OEM, with GMP certification work also being carried out in phases. The products produced and operated by the company include traditional Chinese medicine products such as Xiao'er Qingre Zhike Oral Liquid, Jian'er Qingjie Liquid, Bai'an Lotion, Qingbai Jieshen Lotion, and Guanxin Danshen Capsules, as well as chemical drug varieties such as Compound Pseudoephedrine Hydrochloride Capsules, Azithromycin Dispersible Tablets, and Diclofenac Sodium Sustained-release Tablets. Sinopharm Zhijun (Shenzhen) Pingshan Pharmaceutical takes world-class enterprises as its benchmark and aspires to be a model of China's pharmaceutical industry. Looking ahead, the company will integrate research and development with marketing, guided by technological innovation, to become a quality-leading, core-competitive, horizontally diversified pharmaceutical and health product and service provider with brand influence in both domestic and international markets.